Adiponectin, an adipocitokine, plays a significant role in T2DM and metabolic syndrome, due to its insulin sensitizing anti-inflammatory and anti-atherogenic properties [49]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.